InvestorsHub Logo
Followers 48
Posts 12044
Boards Moderated 0
Alias Born 09/12/2017

Re: Bill_ENG post# 149447

Monday, 03/01/2021 9:00:38 PM

Monday, March 01, 2021 9:00:38 PM

Post# of 233157
vagueness and smoke. Nothing definitive = Nader Pourhassan, Ph.D., President and Chief Executive Officer of CytoDyn, commented, “We are eager to reach conclusion in our discussions with all the regulatory agencies for the path going forward and will release the details of our data and the results of our discussions with regulatory agencies in the coming weeks.” Details of the Company’s ongoing discussions with the regulatory agencies are confidential.
https://www.globenewswire.com/news-release/2021/02/22/2179338/0/en/CytoDyn-in-Discussions-with-U-S-FDA-MHRA-and-Health-Canada-After-Unblinding-its-CD12-Trial-Data-for-Severe-to-Critically-Ill-COVID-19-Patients.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News